Author:
Foust Rick,Clarkson Stephen,Nordberg Megan,Joly Joanna,Griffin Russell,May Jori
Abstract
ABSTRACT
Introduction:
Studies have demonstrated the efficacy of intravenous (IV) iron when administered to patients with congestive heart failure (CHF) and iron deficiency (ID). We aimed to better understand the adherence of treatment for ID among a population with CHF, with particular interest in high-risk groups not often studied due to inadequate recruitment.
Methods:
A retrospective chart review at our institution was conducted from January 1, 2012, to July 7, 2021. Analysis included hospitalized patients with CHF and ID and dividing these patients into two time periods based on changes in iron treatment patterns and treatment between sexes.
Results:
Four thousand eight hundred thirteen patients were included in this study. During the “early era,” 7.0% of patients with CHF and ID received IV iron compared with 20.9% of “late-era” patients. Female patients with ID were statistically less likely to receive IV iron when compared with male patients, both unadjusted (0.66, confidence interval [CI] 0.55–0.79, p < .0001) and adjusted (0.72, CI 0.59–0.87, p < .0001) for covariates.
Conclusion:
This study illustrates improved adherence to treatment for ID among hospitalized population with CHF and ID over time but persistent undertreatment remains. Future studies will need to identify the barriers to treating female patients with CHF and ID to reduce these disparities.
Publisher
Ovid Technologies (Wolters Kluwer Health)